Browse Related Topics For:

Patents

3772
Patent Litigation
3036
Patent Infringement
1458
Patent Trial and Appeal Board
1436
USPTO
1387
Inter Partes Review (IPR) Proceeding
1221
SCOTUS
1160
Patent-Eligible Subject Matter
984
Pharmaceutical Industry
932
Pharmaceutical Patents
783
Appeals
699
America Invents Act
687
Claim Construction
632
Prior Art
609
Patent Applications
553
CLS Bank v Alice Corp
519
Popular
440
Obviousness
394
Patent Invalidity
366
Patent Reform
355
Section 101
339
Infringement
333
Generic Drugs
333
Intellectual Property Protection
311
Abstract Ideas
304
Covered Business Method Patents
304
Trademarks
300
ANDA
299
FDA
283
Post-Grant Review
281
Prescription Drugs
272
Biotechnology
272
Software
270
Copyright
260
EU
251
ITC
235
Mayo v. Prometheus
232
Biosimilars
231
Patent Trolls
223
Myriad
221
DNA
219
Design Patent
217
Induced Infringement
214
Patent-in-Suit
205
BPCIA
205
Covered Business Method Proceedings
202
Hatch-Waxman
200
Trade Secrets
189
Patent Ownership
186
Corporate Counsel
178
Attorney's Fees
173
AMP v Myriad
173
Inventors
172
Summary Judgment
168
Life Sciences
167
FTC
163
Apple
163
IP License
159
Computer-Related Inventions
148
Australia
148
Discovery
144
Damages
140
Personal Jurisdiction
139
Young Lawyers
138
Reversal
134
Venue
133
Human Genes
132
Technology
127
Amgen
127
Octane Fitness v. ICON
126
Willful Infringement
125
Inventions
124
Indefiniteness
124
Medical Devices
122
Evidence
122
Standard Essential Patents
121
Motion to Dismiss
119
En Banc Review
119
Sandoz v Amgen
118
Sandoz
118
Software Patents
116
Patent Exhaustion
116
TC Heartland LLC v Kraft Foods
113
License Agreements
111
Jurisdiction
111
Patent Royalties
110
Patent Prosecution
110
Standing
109
Standard of Review
109
Teva Pharmaceuticals
106
Declaratory Judgments
106
Estoppel
106
Preliminary Injunctions
105
First-to-File
102
Biologics
101
Intellectual Property Litigation
100
Alice Corporation
98
Expert Testimony
97
FRAND
96
Motion to Amend
95
Broadest Reasonable Interpretation Standard
95
China
94
Section 337
93
Royalties
92
CLS Bank
92
Non-Practicing Entities
91
Federal Rules of Civil Procedure
90
Samsung
89
Genetic Materials
88
Direct Infringement
88
Patent Dance
87
Patent Term Adjustment
87
UK
86
Manufacturers
86
Remand
84
Halo v Pulse
84
Nautilus Inc. v. Biosig Instruments
83
Forum Shopping
82
Laches
81
Actavis Inc.
81
Imports
81
Microsoft
81
Teva v Sandoz
79
Apple v Samsung
79
Google
79
Utility Patents
77
Apotex
76
Enhanced Damages
74
De Novo Standard of Review
74
Licenses
74
Patent Validity
73
Novartis
72
Administrative Proceedings
72
Canada
72
Principal Place of Business
71
Certiorari
71
Myriad-Mayo
70
European Patent Office
67
Limelight v Akamai
67
Mylan Pharmaceuticals
66
Motion To Stay
66
Patent Examinations
66
Reverse Payment Settlement Agreements
66
Statute of Limitations
65
On-Sale Bar
64
Innovation Act
63
Antitrust Litigation
62
Cisco v CommilUSA
62
Clear Error Standard
62
FTC v Actavis
62
Proposed Legislation
62
Unified Patent Court
61
Highmark v. Allcare
61
Petition For Rehearing
60
Akamai Technologies
60
Dismissals
60
State of Incorporation
59
Article III
59
Exceptional Case
59
Healthcare
59
Injunctions
59
Joinder
59
Noninfringement
59
Notice Requirements
59
Patent Filings
58
Burden of Proof
58
Good Faith
58
The Patent Act
57
Breach of Contract
57
Commercial Marketing
57
Misappropriation
57
Startups
57
Vacated
56
Impression Products v Lexmark International
55
CAFC
55
First-to-Invent
55
Innovation
55
Written Descriptions
54
Markman Hearing
54
Product of Nature Doctrine
53
Expert Witness
52
AstraZeneca
52
DOJ
52
Inter Partes Reexamination
52
Preemption
52
Preponderance of the Evidence
52
Real Party in Interest
52
Sequenom
52
Settlement
51
Copyright Infringement
51
Kimble v Marvel Enterprises
51
Medtronic
51
Unitary Patent
50
Administrative Procedure Act
50
Patent Assertion Entities
50
Pay-For-Delay
49
Ex Partes Reexamination
49
FDA Approval
49
Judicial Review
48
Foreign Sales
48
Universities
47
Confidential Information
46
Exports
46
Limelight Networks
46
Means-Plus-Function
46
Single-Use/No Resale Restriction
45
ALJ
45
Cisco
45
Eli Lilly
45
EPO
45
Patent Cooperation Treaty
45
Petition for Writ of Certiorari
45
Request for Continued Examination
45
Smartphones
44
35 U.S.C. § 284
44
Final Written Decisions
44
Pfizer
44
Sanctions
44
SCA Hygiene Products Aktiebolag v First Quality Baby Products
43
Bilski
43
Motorola
43
Risk Mitigation
42
Abuse of Discretion
42
Cuozzo Speed Technologies
41
Component Parts Doctrine
41
European Court of Justice (ECJ)
41
Guidance Update
40
Doctrine of Equivalents
40
Patent Portfolios
40
Petrella v. MGM
40
USPTO Pilot Program
39
BRCA
39
Class Action
39
Inequitable Conduct
39
Lanham Act
39
UK Brexit
38
Life Technologies Corp v Promega Corp
38
Pleading Standards
38
Seagate
37
Arbitration
37
Competition
37
Cuozzo Speed Technologies v Lee
37
Depositions
37
Public Comment
37
Sherman Act
36
Brulotte
36
Genetically Engineered Seed
36
Pleadings
36
Stare Decisis
35
Divided Infringement
35
First Sale Doctrine
35
Indirect Infringement
35
Japan
35
Technology Sector
34
Diagnostic Method
34
Disclosure Requirements
34
Method Claims
34
Patent Prosecution Highway
34
Software Developers
34
Watson Pharmaceuticals
33
Abuse of Process
33
Enfish v Microsoft
33
Final Judgment
33
Hospira
33
Injunctive Relief
33
Merck
33
Oral Argument
33
Trademark Registration
33
Validity
32
Bad Faith
32
Judicial Discretion
32
Monsanto
32
Safe Harbors
32
Subject Matter Jurisdiction
31
Advertising
31
Attorney-Client Privilege
31
Automotive Industry
31
Constitutional Challenges
31
Extraterritoriality Rules
31
Food Manufacturers
31
Jury Verdicts
31
Orange Book
31
Resales Agreements
31
Stream of Commerce
30
Allergan Inc
30
Collateral Estoppel
30
Counterclaims
30
Examiners
30
PATENT Act
30
Patent Terms
30
Permanent Injunctions
30
Stem cells
29
Bowman v Monsanto
29
Equitable Estoppel
29
First Amendment
29
Germany
29
Hart-Scott-Rodino Act
29
Honest Belief Defense
29
Legislative Agendas
29
WIPO
28
Chevron Deference
28
Fee-Shifting
28
Genetic Testing
28
Hague Agreement
28
Kappos
28
Litigation Strategies
28
Pending Legislation
28
Stryker v Zimmer
28
The Copyright Act
28
Unfair Competition
27
aBLA
27
Calculation of Damages
27
Limelight
27
Mobile Devices
27
Non-Appealable Decisions
27
Patent Owner Preliminary Response
27
Stays
27
Trade Dress
27
Trademark Infringement
26
Amicus Briefs
26
Cell Phones
26
Foreign Patent Applications
26
Frivolous Lawsuits
26
Genentech
26
Motion To Strike
26
Multidistrict Litigation
25
Antitrust Provisions
25
Australian Patent Office
25
Defense Strategies
25
Gene Patenting
25
Internet
25
IP Assignment Agreements
25
Standard of Proof
24
Defend Trade Secrets Act (DTSA)
24
Due Process
24
Enforcement
24
Forum Selection
24
Judgment on the Pleadings
24
Kirtsaeng v. John Wiley & Sons
24
Motion for Summary Judgment
24
Oil States Energy Services v Greene's Energy Group
24
Public Disclosure
24
Reaffirmation
24
Rule 11
24
Suprema
24
Ultramercial v Hulu
23
ACLU
23
Anticipation
23
Comment Period
23
Data Protection
23
European Commission
23
Hedge Funds
23
Proposed Amendments
23
Provisional Applications
23
Research and Development
22
3D Printing
22
Brooks Furniture
22
European Patent Convention
22
Exclusion Orders
22
Functionality
22
Gilead Sciences
22
GlaxoSmithKline
22
JMOL
22
New Legislation
22
Patent Expiration
22
Reissue Patents
22
Transfer of Venue
21
Acquisitions
21
Antitrust Violations
21
Disparagement
21
Energy Sector
21
Industrial Design
21
Member State
21
Mootness
21
Nintendo
21
RAND
20
Barack Obama
20
Bayer
20
Cybersecurity
20
Diagnostic Tests
20
Filing Deadlines
20
Foreign Investment
20
Licensing Rules
20
Oil & Gas
20
Personalized Medicine
20
Plant Patents
20
Qualcomm
20
Settlement Agreements
20
Sovereign Immunity
20
Sprint
20
Substantial Evidence Standard
20
Trans-Pacific Partnership
20
Twombly/Iqbal Pleading Standard
19
AbbVie
19
Anti-Competitive
19
Bayh-Dole Act
19
Biologics Price Competition and Innovation Act of 2009
19
Cancer
19
Contributory Infringement
19
Enablement Inquiries
19
Interference Proceeding
19
Interim Guidance
19
iPhone
19
Issue Preclusion
19
Joint Infringement
19
New Guidance
19
Protective Orders
19
SEC
19
Unfair or Deceptive Trade Practices
19
Websites
18
Amazon
18
Attorney Malpractice
18
Bascom Global v AT&T Mobility
18
Bristol-Myers Squibb
18
Business Assets
18
Definiteness
18
Facebook
18
Fashion Industry
18
Federal Register
18
International Litigation
18
Motion to Compel
18
Non-Disclosure Agreement
18
Par Pharmaceutical
18
Printed Publications
18
Referendums
18
Right to a Jury
18
Telecommunications
18
Testimony
18
TRIPS Agreement
18
Trump Administration
17
Administrative Procedure
17
Ariosa
17
Auto Manufacturers
17
Commercial Bankruptcy
17
Counterfeiting
17
Cross-Border Transactions
17
Derivation Proceeding
17
Disclosure
17
Due Diligence
17
Eleventh Amendment
17
Entrepreneurs
17
False Advertising
17
Interlocutory Appeals
17
International Arbitration
17
Monopolization
17
Private Property
17
Section 102
17
Seeds
17
STRONG Patents Act
17
Takeda Pharmaceuticals
17
Tariff Act of 1930
17
Trademark Litigation
17
Uniform Commercial Code (UCC)
17
Venture Capital
17
Webinars
16
Ambry
16
Chemicals
16
Clean Tech
16
Contract Term
16
Declaration
16
Dispute Resolution
16
Document Productions
16
Enforcement Actions
16
Federal Rule 12(b)(6)
16
Ford Motor
16
Foreign Corporations
16
Irreparable Harm
16
Judgment As A Matter Of Law
16
Jury Trial
16
Marketing
16
Medtronic v Boston Scientific
16
New Zealand
16
Prevailing Party
16
Section 271
16
Small Business
16
Treble Damages
15
Additional Discovery
15
Allergan v Sandoz
15
Brand
15
Domestic Industry Requirement
15
eBay
15
Endo Pharmaceuticals
15
Generic
15
Janssen Pharmaceuticals
15
Lexmark
15
Mergers
15
Myriad v Ambry
15
Remedies
15
Seventh Amendment
15
Trademark Trial and Appeal Board
15
WTO
14
Affirmative Defenses
14
Assignment of Inventions
14
Covenant Not to Sue
14
Cross Examination
14
Customs
14
DMCA
14
Double Patent
14
E-Commerce
14
Fashion Design
14
Fast Track Process
14
Free Speech
14
Innovation Patent
14
Legal Perspectives
14
Lost Profits
14
Micro Entity Status
14
Priority Patent Claims
14
Proposed Regulation
14
PTO
14
Roxane Laboratories
14
The Patent Box
14
Totality of Circumstances Test
14
Uniform Trade Secrets Acts
14
Wireless Technology
13
Abuse of Dominance
13
Ambiguous
13
Animation
13
Article of Manufacture
13
Assignor Estoppel
13
Cephalon
13
Confidentiality Agreements
13
Cross-Border
13
Failure To State A Claim
13
Federal Jurisdiction
13
Fees
13
Filing Fees
13
Final Rules
13
Fraud
13
Grace Period
13
Investors
13
Italy
13
Joint Inventors
13
Likelihood of Confusion
13
Litigation Fees & Costs
13
Mobile Apps
13
Nanotechnology
13
Patent Fees
13
Patent Oppositions
13
Pre-GATT
13
Prior User
13
Scope of the Claim
13
Separation of Powers
13
Social Media
13
Supreme Court of Canada
13
Third-Party
13
Writ of Mandamus
12
AFCP
12
AT&T Mobility
12
Corporate Taxes
12
Daubert Standards
12
Divisional Applications
12
Dow Chemical
12
Employment Contract
12
Ex Parte
12
Federal Pilot Programs
12
Inventive Concept Test
12
Investigations
12
LG Electronics
12
Miniauction
12
Motion to Transfer
12
Nokia
12
Order to Stay
12
Patent Agent Privilege
12
Patentability Search
12
Profits
12
Public Interest
12
Public Property
12
Public Use
12
Res Judicata
12
Right of Publicity
12
SIPO
12
SSO
12
Star Athletica v Varsity Brands
12
Sua Sponte
12
Supplemental Evidence
12
Supplemental Examination
12
Suppliers
12
Versata
12
Video Games
11
Affordable Care Act
11
AIPLA
11
Amended Complaints
11
Arbitration Agreements
11
Assignments
11
Biopharmaceutical
11
Burden of Production
11
Burden-Shifting
11
Cease and Desist Orders
11
Claim Preclusion
11
Compliance
11
Dell
11
Demand Letter
11
Domain Names
11
Electronics
11
Exclusive Licenses
11
Expiration Date
11
Federal Contractors
11
Filing Requirements
11
Garmin International
11
General Electric
11
Gunn v Minton
11
IEEE
11
IPO
11
Legislative Committees
11
Manufacturer Liability
11
Marvel Comics
11
Motion for Judgment
11
Motion for Reconsideration
11
Motions in Limine
11
Patent Amendments
11
Patent Term Extensions
11
Petitions for Review
11
Reviewability Determinations
11
RICO
11
SAP America Inc.
11
Work Product Privilege
10
Antitrust Investigations
10
Applications
10
Cease and Desist
10
CETA
10
Comcast
10
Contract Terms
10
CRISPR
10
Customs and Border Protection
10
Data Collection
10
Drug Pricing
10
Electronic Data Transmissions
10
Extrinsic Evidence
10
Fair Use
10
Farms
10
FDCA
10
Fresenius
10
Highmark
10
Holidays
10
IBM
10
Injury-in-Fact
10
Joint Venture
10
Kraft
10
Licensing Rights
10
McRo v Bandai Namco
10
Mediation
10
Medical Research
10
Misrepresentation
10
Motion for Sanctions
10
Nonobvious
10
Physicians
10
Presumption of Validity
10
Price-Fixing
10
Privity of Contract
10
Product Labels
10
Ratification
10
Registration
10
Rulemaking Process
10
SAS Institute Inc. v Lee
10
State Law Claims
10
Supplemental Information
10
Supplementary Protection Certificate
10
Symantec
10
Transparency
10
Twitter
10
USTR
10
UTSA
10
Waivers
9
Algorithms
9
Anti-Dumping Duty
9
Anti-Monopoly
9
Anticipatory Reference
9
Asset Seizure
9
AT&T
9
Barnes and Noble
9
Burden of Persuasion
9
Case Consolidation
9
Cloud Computing
9
Copyright Litigation
9
Cross-Licensing Agreement
9
DDR Holdings v Hotels.com
9
Doctrine of Prosecution Disclaimer
9
Duty of Candor
9
Exclusions
9
Expedited Actions Process
9
FCPA
9
Food Labeling
9
Foreign Jurisdictions
9
Hana Financial v Hana Bank
9
Health Care Providers
9
Indemnification
9
India
9
Information Disclosure Statement
9
Inherency
9
Intel
9
Interference Claims
9
International Harmonization
9
JPO
9
Jury Awards
9
Mandamus Petitions
9
Motion to Exclude
9
MPEP
9
NAFTA
9
National Cancer Moonshot
9
New Trial
9
Oracle
9
OTDP
9
Patent Law Treaty
9
PHRMA
9
Product Exclusivity
9
Rule-of-Reason Analysis
9
Salesforce
9
Scientific Research
9
Section 103
9
Split of Authority
9
Subsidiaries
9
Terminal Disclaimer
9
Trade Agreements
9
Transfers
8
Abbott Laboratories
8
Adobe
8
Alien Tort Statute
8
Apportionment
8
B&B Hardware v Hargis Industries
8
Cartels
8
Cheerleaders
8
Classen Immunotherapies
8
Clear and Convincing Evidence
8
Clinical Trials
8
Community Designs
8
Compulsory Licenses
8
Copyright Office
8
Cybor Corp v FAS Technologies
8
DaimlerChrysler v Bauman
8
Declaratory Relief
8
Disclaimers
8
Draft Guidance
8
Ericsson
8
False Claims Act (FCA)
8
Form 18
8
France
8
GMO
8
Graphical User Interface
8
gTLD
8
Health Insurance
8
Hewlett-Packard
8
Hospitals
8
HTC
8
Intellectual Property Owners Association
8
JPMorgan Chase
8
Motion to Terminate
8
Music
8
Nexus
8
Obama Administration
8
OECD
8
Premerger Notifications
8
Private Right of Action
8
Prometheus
8
Rebuttable Presumptions
8
Retailers
8
Reversible Error
8
Sanofi-Aventis
8
Securities Fraud
8
Solicitor General
8
Sony
8
Supply Chain
8
Tacking
8
Theft
8
Tortious Interference
8
Toshiba
8
Toyota
8
Treatment Method Patents
8
Walker Process Claims
8
Wearable Technology
8
Wyeth
7
ACIP
7
Agency Deference
7
Analogous Art
7
Anticompetitive Agreements
7
AOL
7
Arbitration Awards
7
Article 50 Treaty of the EU
7
Audits
7
Banks
7
Blackberry
7
Brazil
7
Commercial General Liability Policies
7
Competition Authorities
7
Conflicts of Interest
7
Continuing Legal Education
7
Contract Interpretation
7
Countervailing Duties
7
Databases
7
Digital Media
7
Dismissal With Prejudice
7
Economic Espionage Act
7
Effective Filing Date
7
Email
7
Encryption
7
Equitable Relief
7
European Union Trade Mark (EUTM)
7
Federal Rules of Evidence
7
Final Action
7
Financial Products
7
Genzyme
7
Inherent Disclosure Doctrine
7
Internet Service Providers (ISPs)
7
Internet Streaming
7
Judges
7
Labeling
7
Limitation Periods
7
Local Rules
7
Minimum Contacts
7
MOFCOM
7
Multinationals
7
NIH
7
Nike
7
Noerr-Pennington Doctrine
7
Objective Unreasonableness Standard
7
Online Gaming
7
PLTIA
7
PMNOC Regulations
7
Prejudgment Interest
7
Putative Class Actions
7
Raising The Bar Act
7
Reasonable Certainty Standard
7
Rules of Practice
7
Securities
7
Shire Development v Watson
7
South Korea
7
Spoliation
7
Subject Matter Experts
7
Supply Contracts
7
Target
7
Tariffs
7
Technology Transfer Agreements
7
Tesla
7
The Clayton Act
7
Time Extensions
7
Trials
7
U.S. Commerce Department
7
Uniforms
7
Unjust Enrichment
7
USDA
7
Warner Chilcott
7
White Collar Crimes
7
WildTangent v Ultramercial
7
YouTube
6
Administrative Appeals
6
Admissible Evidence
6
Airlines
6
Amended Regulation
6
Banking Sector
6
Bankruptcy Code
6
BEPS
6
Best Practices
6
Bifurcation
6
Big Data
6
Biofuel
6
Biogen Idec
6
Bitcoin
6
Canadian Intellectual Property Office
6
Claim Amendments
6
Collaboration
6
Computer Fraud and Abuse Act (CFAA)
6
Consent Order
6
Contempt
6
Continuation Applications
6
Coopertive Patent Classification System
6
Copyrightable Subject Matter
6
Court of Federal Claims
6
Criminal Prosecution
6
Deadlines
6
Delays
6
Disgorgement
6
Driverless Cars
6
eBay Test
6
Educational Institutions
6
Electronic Filing
6
Enhanced Penalties
6
Entertainment Industry
6
Evidentiary Rulings
6
Exclusivity
6
Fair Market Value
6
Federal Arbitration Act
6
Federal Question Jurisdiction
6
Forum
6
Forward Publishing
6
FSIA
6
FTAIA
6
GAO
6
Garmin Factors
6
Genuine Issue of Material Fact
6
Grable Factors
6
Health Canada
6
Hearsay
6
Hiring & Firing
6
HTC America
6
Huawei
6
Hulu
6
Inducement
6
Information Reports
6
Insider Trading
6
Insurance Industry
6
Internet of Things
6
IPEC
6
IRS
6
Jazz Pharmaceuticals
6
Judge Rakoff
6
Legal History
6
Local Patent Rules
6
Memorandum of Guidance
6
Music Industry
6
New Regulations
6
Nexium
6
NLRB
6
Opt-Outs
6
Otsuka Pharmaceutical
6
Parallel Claims
6
Paris Convention
6
Pharmacies
6
Primary Residence
6
Prioritized Examination
6
Priority Date Cutoff
6
Privacy Laws
6
Private Sales
6
Redskins
6
Renewable Energy
6
Reputational Injury
6
Reverse Payments
6
Roslin
6
Rule 36
6
Rules of Civil Procedure
6
Russia
6
Scams
6
Scienter
6
Specific Jurisdiction
6
Sports
6
Strategic Planning
6
Sunrise Periods
6
Tax Rates
6
Telemedicine
6
TFEU
6
The Enlarged Board of Appeals
6
Third-Party Relationships
6
Time-Barred Claims
6
Trade Relations
6
Wireless Devices
5
3-D Technology
5
510(k) RTA
5
Administrative Authority
5
Anticompetitive Behavior
5
Antitrust Division
5
Antitrust Injuries
5
Artificial Intelligence
5
Asia
5
Boilerplate Language
5
Broadcasting
5
Canon
5
Carnegie Mellon
5
Class Certification
5
Co-Ownership
5
Coca Cola
5
Common-Interest Privilege
5
Competition Act
5
Confidential Documents
5
Connected Cars
5
Contract Disputes
5
COPPA
5
Copyrights
5
Cox Communications
5
Data Privacy
5
Deceptive Intent
5
Defamation
5
Default Judgment
5
Designs Act
5
Determination on Remand
5
Digital Goods
5
Digital Health
5
Drug Approvals
5
Duty to Defend
5
EEA
5
Elan Pharmaceuticals
5
Elon Musk
5
Emerging Growth Companies
5
End-Users
5
European Union Intellectual Property Office (EUIPO)
5
Exelixis
5
False Statements
5
Fiduciary Duty
5
Film Industry
5
Financial Institutions
5
Financing
5
Fitbit
5
Forum Non Conveniens
5
Fracking
5
FTC Act
5
Function-Way-Result Test
5
Gaming
5
Graham Factors
5
HHS
5
HIPAA
5
Honda
5
Honeywell International
5
Hotels.com
5
ICANN